Holmes Scott A
Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC; SVP, Finance and Treasurer at ADVANCED MAGNETICS INC
- Sold, on record
- $2.3M
- Dollars the filings state
- Form 4 sales
- 21
- Latest Nov 15, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- KERYX BIOPHARMACEUTICALS INCChief Financial Officer
- ADVANCED MAGNETICS INCSVP, Finance and Treasurer
Sales by reason
0
Routine
16
Plan not stated
0
No plan
5
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- KERYX BIOPHARMACEUTICALS INC43,294 shares
- ADVANCED MAGNETICS INC33,346 shares
Shares sold, every Form 4 sale on record.
Timeline
- Nov 15, 2018Plan not stated
Sold 0.7% of their holdings
$3k1,155 shares at $2.77
- Oct 29, 2018Plan not stated
Sold 0.8% of their holdings
$4k1,254 shares at $3.07
- Aug 15, 2018Plan not stated
Sold 0.7% of their holdings
$4k1,185 shares at $3.04
- Jul 30, 2018Plan not stated
Sold 1.4% of their holdings
$9k2,354 shares at $3.86
- May 15, 2018Plan not stated
Sold 0.7% of their holdings
$7k1,158 shares at $5.69
- Apr 30, 2018Plan not stated
Sold 1.4% of their holdings
$11k2,407 shares at $4.67
- Feb 15, 2018Unusual
Sold 4.1% of their holdings
$27k5,651 shares at $4.81
- Jan 29, 2018Plan not stated
Sold 2% of their holdings
$14k2,830 shares at $4.81
- Oct 30, 2017Plan not stated
Sold 1.8% of their holdings
$16k2,582 shares at $6.03
- Jul 31, 2017Plan not stated
Sold 1% of their holdings
$10k1,445 shares at $7.14
10 of 21
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2018 | Dec 13, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Returned to the companyStock Option | 902,500 | 0 | SEC | ||
| Dec 12, 2018 | Dec 13, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Returned to the company | 162,956 | 0 | SEC | ||
| Nov 15, 2018 | Nov 16, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 1,155 | $2.77 | $3k | 162,956 | SEC |
| Oct 29, 2018 | Oct 30, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 1,254 | $3.07 | $4k | 164,111 | SEC |
| Aug 15, 2018 | Aug 16, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 1,185 | $3.04 | $4k | 165,365 | SEC |
| Jul 30, 2018 | Jul 31, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 2,354 | $3.86 | $9k | 166,550 | SEC |
| May 15, 2018 | May 16, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 1,158 | $5.69 | $7k | 168,904 | SEC |
| Apr 30, 2018 | May 1, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 2,407 | $4.67 | $11k | 170,062 | SEC |
| Mar 20, 2018 | Mar 22, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | AwardedStock Options (right to buy) | 82,500 | 82,500 | SEC | ||
| Mar 20, 2018 | Mar 22, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Awarded | 41,250 | 172,469 | SEC | ||
| Feb 15, 2018 | Feb 16, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 5,651 | $4.81 | $27k | 131,219 | SEC |
| Jan 29, 2018 | Jan 31, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 2,830 | $4.81 | $14k | 136,870 | SEC |
| Oct 30, 2017 | Oct 31, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 2,582 | $6.03 | $16k | 139,700 | SEC |
| Jul 31, 2017 | Aug 1, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 1,445 | $7.14 | $10k | 142,282 | SEC |
| Jul 28, 2017 | Jul 31, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 1,236 | $6.96 | $9k | 143,727 | SEC |
| May 1, 2017 | May 3, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 1,441 | $5.97 | $9k | 144,963 | SEC |
| Apr 28, 2017 | May 1, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 1,219 | $5.89 | $7k | 146,404 | SEC |
| Feb 14, 2017 | Mar 15, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | AwardedEmployee Stock Option (Right to Buy) | 97,500 | 97,500 | SEC | ||
| Feb 14, 2017 | Mar 15, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Awarded | 48,750 | 147,623 | SEC | ||
| Jan 30, 2017 | Jan 31, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 8,447 | $4.65 | $39k | 98,873 | SEC |
| Oct 28, 2016 | Oct 31, 2016 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 1,237 | $4.44 | $5k | 107,320 | SEC |
| Jul 29, 2016 | Aug 2, 2016 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 4,935 | $7.36 | $36k | 108,557 | SEC |
| Jan 28, 2016 | Feb 1, 2016 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | AwardedEmployee Stock Option (Right to Buy) | 107,500 | 107,500 | SEC | ||
| Jan 28, 2016 | Feb 1, 2016 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Awarded | 53,750 | 113,492 | SEC | ||
| Nov 4, 2015 | Nov 5, 2015 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Bought | 5,000 | $5.33 | $27k | 59,742 | SEC |
| Aug 21, 2015 | Aug 24, 2015 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Bought | 5,000 | $5.72 | $29k | 54,742 | SEC |
| Jul 31, 2015 | Aug 3, 2015 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Sold | 2,758 | $7.87 | $22k | 49,742 | SEC |
| Jun 15, 2015 | Jun 17, 2015 | ADVANCED MAGNETICS INC | SVP, Finance and Treasurer | Sold | 7,580 | $66.63 | $505k | 51,958 | SEC |
| Jun 15, 2015 | Jun 17, 2015 | ADVANCED MAGNETICS INC | SVP, Finance and Treasurer | Exercised or settledStock Option (Right to Buy) | 6,234 | 11,500 | SEC | ||
| Jun 15, 2015 | Jun 17, 2015 | ADVANCED MAGNETICS INC | SVP, Finance and Treasurer | Exercised options | 6,234 | $15.82 | $99k | 58,192 | SEC |
| Jun 3, 2015 | Jun 5, 2015 | ADVANCED MAGNETICS INC | SVP, Finance and Treasurer | Sold | 22,516 | $68.88 | $1.6M | 30,788 | SEC |
| Mar 3, 2015 | Mar 5, 2015 | ADVANCED MAGNETICS INC | SVP, Chief Accounting Officer | Withheld for tax | 533 | $49.70 | $26k | 53,304 | SEC |
| Feb 26, 2015 | Feb 27, 2015 | ADVANCED MAGNETICS INC | SVP, Chief Accounting Officer | AwardedStock Option (Right to Buy) | 10,000 | 10,000 | SEC | ||
| Feb 26, 2015 | Feb 27, 2015 | ADVANCED MAGNETICS INC | SVP, Chief Accounting Officer | Awarded | 5,000 | 53,837 | SEC | ||
| Dec 17, 2014 | Dec 18, 2014 | ADVANCED MAGNETICS INC | SVP, Chief Accounting Officer | Withheld for tax | 859 | $40.49 | $35k | 48,837 | SEC |
| Aug 19, 2014 | Aug 21, 2014 | ADVANCED MAGNETICS INC | SVP, Chief Accounting Officer | Awarded | 20,000 | 49,696 | SEC | ||
| Jun 11, 2014 | Jun 11, 2014 | ADVANCED MAGNETICS INC | SVP, Chief Accounting Officer | AwardedStock Option (Right to Buy) | 30,000 | 30,000 | SEC | ||
| Jun 11, 2014 | Jun 11, 2014 | ADVANCED MAGNETICS INC | SVP, Chief Accounting Officer | Awarded | 15,000 | 29,696 | SEC | ||
| Feb 27, 2014 | Feb 28, 2014 | ADVANCED MAGNETICS INC | VP, Chief Accounting Officer | AwardedStock Option (Right to Buy) | 18,800 | 18,800 | SEC | ||
| Feb 27, 2014 | Feb 28, 2014 | ADVANCED MAGNETICS INC | VP, Chief Accounting Officer | Awarded | 3,100 | 14,696 | SEC | ||
| Dec 16, 2013 | Dec 17, 2013 | ADVANCED MAGNETICS INC | VP, Chief Accounting Officer | Withheld for tax | 654 | $23.23 | $15k | 11,596 | SEC |
| Feb 28, 2013 | Mar 4, 2013 | ADVANCED MAGNETICS INC | VP, Chief Accounting Officer | AwardedStock Option (Right to Buy) | 15,000 | 15,000 | SEC | ||
| Feb 28, 2013 | Mar 4, 2013 | ADVANCED MAGNETICS INC | VP, Chief Accounting Officer | Awarded | 7,500 | 7,500 | SEC | ||
| Dec 5, 2012 | Dec 6, 2012 | ADVANCED MAGNETICS INC | Chief Accounting Officer | Sold | 2,500 | $14.79 | $37k | 0 | SEC |
| Dec 5, 2012 | Dec 6, 2012 | ADVANCED MAGNETICS INC | Chief Accounting Officer | Exercised or settledRestricted Stock Units | 2,500 | 2,500 | SEC | ||
| Dec 5, 2012 | Dec 6, 2012 | ADVANCED MAGNETICS INC | Chief Accounting Officer | Exercised options | 2,500 | 2,500 | SEC | ||
| Sep 12, 2012 | Sep 13, 2012 | ADVANCED MAGNETICS INC | Chief Accounting Officer | Sold | 750 | $15.54 | $12k | 0 | SEC |
| Sep 12, 2012 | Sep 13, 2012 | ADVANCED MAGNETICS INC | Chief Accounting Officer | ConvertedRestricted Stock Unit | 750 | 750 | SEC | ||
| Sep 12, 2012 | Sep 13, 2012 | ADVANCED MAGNETICS INC | Chief Accounting Officer | Converted | 750 | 750 | SEC | ||
| Jun 25, 2012 | Jun 27, 2012 | ADVANCED MAGNETICS INC | Chief Accounting Officer | AwardedStock Options | 30,000 | 30,000 | SEC |
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2018 | Nov 16, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,155 | $3k | 0.7% | Plan not stated | SEC |
| Oct 29, 2018 | Oct 30, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,254 | $4k | 0.8% | Plan not stated | SEC |
| Aug 15, 2018 | Aug 16, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,185 | $4k | 0.7% | Plan not stated | SEC |
| Jul 30, 2018 | Jul 31, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,354 | $9k | 1.4% | Plan not stated | SEC |
| May 15, 2018 | May 16, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,158 | $7k | 0.7% | Plan not stated | SEC |
| Apr 30, 2018 | May 1, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,407 | $11k | 1.4% | Plan not stated | SEC |
| Feb 15, 2018 | Feb 16, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 5,651 | $27k | 4.1% | Unusual | SEC |
| Jan 29, 2018 | Jan 31, 2018 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,830 | $14k | 2.0% | Plan not stated | SEC |
| Oct 30, 2017 | Oct 31, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,582 | $16k | 1.8% | Plan not stated | SEC |
| Jul 31, 2017 | Aug 1, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,445 | $10k | 1.0% | Plan not stated | SEC |
| Jul 28, 2017 | Jul 31, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,236 | $9k | 0.9% | Plan not stated | SEC |
| May 1, 2017 | May 3, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,441 | $9k | 1.0% | Plan not stated | SEC |
| Apr 28, 2017 | May 1, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,219 | $7k | 0.8% | Plan not stated | SEC |
| Jan 30, 2017 | Jan 31, 2017 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 8,447 | $39k | 7.9% | Unusual | SEC |
| Oct 28, 2016 | Oct 31, 2016 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,237 | $5k | 1.1% | Plan not stated | SEC |
| Jul 29, 2016 | Aug 2, 2016 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 4,935 | $36k | 4.3% | Plan not stated | SEC |
| Jul 31, 2015 | Aug 3, 2015 | KERYX BIOPHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,758 | $22k | 5.3% | Plan not stated | SEC |
| Jun 15, 2015 | Jun 17, 2015 | ADVANCED MAGNETICS INC | SVP, Finance and Treasurer | Form 4 sale | 7,580 | $505k | 12.7% | Plan not stated | SEC |
| Jun 3, 2015 | Jun 5, 2015 | ADVANCED MAGNETICS INC | SVP, Finance and Treasurer | Form 4 sale | 22,516 | $1.6M | 42.2% | Unusual | SEC |
| Dec 5, 2012 | Dec 6, 2012 | ADVANCED MAGNETICS INC | Chief Accounting Officer | Form 4 sale | 2,500 | $37k | 100.0% | Unusual | SEC |
| Sep 12, 2012 | Sep 13, 2012 | ADVANCED MAGNETICS INC | Chief Accounting Officer | Form 4 sale | 750 | $12k | 100.0% | Unusual | SEC |